IBDEI21Z ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,34418,2)
 ;;=^5004035
 ;;^UTILITY(U,$J,358.3,34419,0)
 ;;=G57.00^^157^1750^13
 ;;^UTILITY(U,$J,358.3,34419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34419,1,3,0)
 ;;=3^Lesion Sciatic Nerve,Unspec Lower Limb
 ;;^UTILITY(U,$J,358.3,34419,1,4,0)
 ;;=4^G57.00
 ;;^UTILITY(U,$J,358.3,34419,2)
 ;;=^5004038
 ;;^UTILITY(U,$J,358.3,34420,0)
 ;;=G57.10^^157^1750^15
 ;;^UTILITY(U,$J,358.3,34420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34420,1,3,0)
 ;;=3^Meralgia Paresthetica,Unspec Lower Limb
 ;;^UTILITY(U,$J,358.3,34420,1,4,0)
 ;;=4^G57.10
 ;;^UTILITY(U,$J,358.3,34420,2)
 ;;=^5004041
 ;;^UTILITY(U,$J,358.3,34421,0)
 ;;=G57.90^^157^1750^17
 ;;^UTILITY(U,$J,358.3,34421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34421,1,3,0)
 ;;=3^Mononeuropathy,Unspec Lower Limb
 ;;^UTILITY(U,$J,358.3,34421,1,4,0)
 ;;=4^G57.90
 ;;^UTILITY(U,$J,358.3,34421,2)
 ;;=^5004061
 ;;^UTILITY(U,$J,358.3,34422,0)
 ;;=G58.7^^157^1750^16
 ;;^UTILITY(U,$J,358.3,34422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34422,1,3,0)
 ;;=3^Mononeuritis Multiplex
 ;;^UTILITY(U,$J,358.3,34422,1,4,0)
 ;;=4^G58.7
 ;;^UTILITY(U,$J,358.3,34422,2)
 ;;=^5004063
 ;;^UTILITY(U,$J,358.3,34423,0)
 ;;=G60.0^^157^1750^8
 ;;^UTILITY(U,$J,358.3,34423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34423,1,3,0)
 ;;=3^Hereditary Motor & Sensory Neuropathy
 ;;^UTILITY(U,$J,358.3,34423,1,4,0)
 ;;=4^G60.0
 ;;^UTILITY(U,$J,358.3,34423,2)
 ;;=^5004067
 ;;^UTILITY(U,$J,358.3,34424,0)
 ;;=G60.3^^157^1750^9
 ;;^UTILITY(U,$J,358.3,34424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34424,1,3,0)
 ;;=3^Idiopathic Progressive Neuropathy
 ;;^UTILITY(U,$J,358.3,34424,1,4,0)
 ;;=4^G60.3
 ;;^UTILITY(U,$J,358.3,34424,2)
 ;;=^5004069
 ;;^UTILITY(U,$J,358.3,34425,0)
 ;;=G62.0^^157^1750^7
 ;;^UTILITY(U,$J,358.3,34425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34425,1,3,0)
 ;;=3^Drug-Induced Polyneuropathy
 ;;^UTILITY(U,$J,358.3,34425,1,4,0)
 ;;=4^G62.0
 ;;^UTILITY(U,$J,358.3,34425,2)
 ;;=^5004075
 ;;^UTILITY(U,$J,358.3,34426,0)
 ;;=G62.1^^157^1750^1
 ;;^UTILITY(U,$J,358.3,34426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34426,1,3,0)
 ;;=3^Alcoholic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,34426,1,4,0)
 ;;=4^G62.1
 ;;^UTILITY(U,$J,358.3,34426,2)
 ;;=^5004076
 ;;^UTILITY(U,$J,358.3,34427,0)
 ;;=G63.^^157^1750^21
 ;;^UTILITY(U,$J,358.3,34427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34427,1,3,0)
 ;;=3^Polyneuropathy in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,34427,1,4,0)
 ;;=4^G63.
 ;;^UTILITY(U,$J,358.3,34427,2)
 ;;=^5004080
 ;;^UTILITY(U,$J,358.3,34428,0)
 ;;=G70.00^^157^1750^20
 ;;^UTILITY(U,$J,358.3,34428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34428,1,3,0)
 ;;=3^Myasthenia Gravis w/o Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,34428,1,4,0)
 ;;=4^G70.00
 ;;^UTILITY(U,$J,358.3,34428,2)
 ;;=^329920
 ;;^UTILITY(U,$J,358.3,34429,0)
 ;;=G70.01^^157^1750^19
 ;;^UTILITY(U,$J,358.3,34429,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34429,1,3,0)
 ;;=3^Myasthenia Gravis w/ Acute Exacerbation
 ;;^UTILITY(U,$J,358.3,34429,1,4,0)
 ;;=4^G70.01
 ;;^UTILITY(U,$J,358.3,34429,2)
 ;;=^329921
 ;;^UTILITY(U,$J,358.3,34430,0)
 ;;=G70.80^^157^1750^12
 ;;^UTILITY(U,$J,358.3,34430,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34430,1,3,0)
 ;;=3^Lambert-Eaton Syndrome,Unspec
 ;;^UTILITY(U,$J,358.3,34430,1,4,0)
 ;;=4^G70.80
 ;;^UTILITY(U,$J,358.3,34430,2)
 ;;=^340608
 ;;^UTILITY(U,$J,358.3,34431,0)
 ;;=G72.0^^157^1750^6
 ;;^UTILITY(U,$J,358.3,34431,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,34431,1,3,0)
 ;;=3^Drug-Induced Myopathy
 ;;^UTILITY(U,$J,358.3,34431,1,4,0)
 ;;=4^G72.0
